Skip to main content

Home/ Nutrition/ Group items matching "HAM-D" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Matti Narkia

JAMA -- Abstract: Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial, October 21, 2009, Carney et al. 302 (15): 1651 - 0 views

jama.ama-assn.org/...1651

2009 October JAMA study research clinical_trial rct humans patients depression CHD CVD sertraline Zoloft Lustral omega-3 augmentation supplementation nutrition medline anti-depressant EPA DHA E-EPA BDI-II BDI HAM-D major

shared by Matti Narkia on 16 Nov 09 - Cached
  • Matti Narkia on 16 Nov 09
     
    Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. JAMA. 2009 Oct 21;302(15):1651-7. PMID: 19843899 Conclusions Treatment of patients with CHD and major depression with sertraline and omega-3 fatty acids did not result in superior depression outcomes at 10 weeks, compared with sertraline and placebo. Whether higher doses of omega-3 or sertraline, a different ratio of EPA to DHA, longer treatment, or omega-3 monotherapy can improve depression in patients with CHD remains to be determined
1 - 1 of 1
Showing 20▼ items per page